Boswellia for Women: Are There Any Special Considerations?
Boswellia serrata, also sold as Indian frankincense, has moved from Ayurvedic tradition into mainstream joint-support supplements. Women make up a large share of buyers, partly because knee osteoarthritis is more common in women, especially after menopause. But does sex actually change how boswellia works, who should avoid it, or how to choose a product? Here is what the evidence supports.
What boswellia is and how it is thought to work
Boswellia supplements are made from the gum resin of the Boswellia serrata tree. The active fraction consists mainly of boswellic acids, with 3-O-acetyl-11-keto-β-boswellic acid (AKBA) receiving the most research attention.
In laboratory studies, boswellic acids inhibit 5-lipoxygenase, an enzyme that produces leukotrienes, which are inflammatory signaling molecules. They also appear to influence other inflammatory pathways and enzymes that break down cartilage. This profile differs from that of common NSAIDs such as ibuprofen, which act mainly on cyclooxygenase.
Human trials have focused primarily on knee osteoarthritis. Several randomized trials, including those using standardized extracts enriched in AKBA, reported improvements in pain and function scores compared with placebo over periods of one to three months.
A 2020 systematic review and meta-analysis (Yu et al.) concluded that boswellia and its extracts may be an effective and safe option for osteoarthritis symptoms, while noting that many trials were small and of variable quality. That is a fair summary: promising, not definitive.
Do women respond differently?
No well-powered trial has been designed to compare men and women directly on boswellia. Most osteoarthritis studies enrolled mixed groups, often with a majority of women, and did not report clear sex-specific differences in benefit.
What differs is the background. Women have a higher prevalence of knee and hand osteoarthritis, and the curve steepens after menopause, when the drop in estrogen appears to affect cartilage, bone and connective tissue. This is why boswellia is so often marketed to women over 45.
For active younger women, the use case is different. Runners, CrossFit athletes and team-sport players may look to boswellia for overuse aches. Evidence in this population is very limited; nearly all clinical data come from people with diagnosed osteoarthritis.
Body size may matter in practice. Many studies used fixed doses regardless of body weight, so a smaller woman receives a relatively larger dose per kilogram. There is no evidence this is harmful, but it is another reason to start at the lower end of the labeled range.
Pregnancy, breastfeeding and hormonal questions
This is the area where women genuinely need special consideration. Traditional sources describe boswellia as having possible effects on the uterus and menstrual flow, and there are no reliable safety studies in pregnancy.
For that reason, the general consensus among clinicians and the US National Institutes of Health resources on herbal products is to avoid boswellia during pregnancy and breastfeeding unless a physician specifically advises otherwise.
Some online sources claim boswellia "balances hormones" or treats endometriosis or PCOS. These claims rest on cell or animal studies at most. There is no clinical evidence that boswellia alters estrogen or progesterone levels in women in a meaningful way.
Women taking hormonal contraception or menopausal hormone therapy have no well-documented interaction with boswellia, but the absence of evidence is not proof of safety. Mention the supplement to your clinician, particularly if you also take other medications.
Safety, interactions and choosing a product
In trials, boswellia has generally been well tolerated. The most commonly reported side effects are mild gastrointestinal complaints such as nausea, acid reflux or diarrhea. Allergic skin reactions are possible but uncommon.
Potential interactions worth discussing with a clinician include:
- Anticoagulants and antiplatelet drugs, because of theoretical effects on platelet function;
- NSAIDs, mostly due to additive gastrointestinal effects;
- Drugs metabolized via certain cytochrome P450 enzymes or transported by P-glycoprotein, based on laboratory data;
- Immunosuppressants, given boswellia's effects on immune signaling.
In the US, boswellia is sold as a dietary supplement under DSHEA, which means the FDA does not approve products before sale. Quality depends heavily on the manufacturer. Look for a standardized extract that states the percentage of boswellic acids or AKBA, a third-party testing seal (such as USP or NSF), and a dose comparable to those used in trials.
| Label item | What to look for |
|---|---|
| Extract standardization | Stated % of total boswellic acids or AKBA |
| Daily amount | Within ranges used in clinical studies, typically 100–1000 mg/day of extract depending on standardization |
| Third-party testing | USP, NSF or similar certification |
| Other ingredients | Watch for proprietary blends that hide the actual boswellia amount |
Conclusions from the editorial team
Boswellia does not appear to work differently in women than in men, and the clinical evidence for knee osteoarthritis applies broadly. The main sex-specific point is safety: avoid it during pregnancy and breastfeeding unless a physician advises otherwise.
Expect modest symptom relief over weeks, not a cure. Choose a standardized extract with third-party testing and discuss it with your clinician if you take blood thinners or other regular medications.
Claims that boswellia balances female hormones lack clinical support and should be treated with skepticism.
If this topic interests you, consider reading our pieces on magnesium for women, BCAA for women, and resistance training after 50.
References
- Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3–7.
- Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008;10(4):R85.
- Yu G, Xiang W, Zhang T, et al. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement Med Ther. 2020;20(1):225.
- Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006;72(12):1100–1116.
- Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011;73(3):255–261.
- Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–1759.
